PA
BOW

PharVision Advisers’s Bowhead Specialty Holdings BOW Stock Holding History

PharVision Advisers’s Portfolio BOW Stock Details BOW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-22,482
Closed -$608K – 1054
2025
Q3 		$608K Buy
+22,482
New +$704K 0.34% 9

Other funds holding BOW

GPC
Gallatin Point Capital Greenwich, Connecticut $238M AUM 37.44% 1-Year Est. Return
AFI
American Family Investments Madison, Wisconsin $3.8B AUM 0.71% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PharVision Advisers's BOW Position: Q4 2025 in Review

PharVision Advisers sold out of Bowhead Specialty Holdings (BOW) in Q4 2025, closing a stake of 22,482 shares — an estimated $608K sold.

PharVision Advisers first reported a position in BOW in Q3 2025 and held it in 1 quarter. The position peaked at $608K in Q3 2025. 164 funds tracked by Wall St. Rank hold BOW as of Q4 2025.

  • PharVision Advisers reported no remaining Bowhead Specialty Holdings position as of Q4 2025 after selling out during the quarter.
  • PharVision Advisers sold 22,482 Bowhead Specialty Holdings shares in Q4 2025, an estimated $608K.
  • PharVision Advisers first reported a position in Bowhead Specialty Holdings in Q3 2025 and held it in 1 quarter.
  • PharVision Advisers's Bowhead Specialty Holdings position peaked at $608K in Q3 2025.
  • 164 funds tracked by Wall St. Rank held Bowhead Specialty Holdings as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.